352 related articles for article (PubMed ID: 17496757)
21. Choosing a right surfactant for respiratory distress syndrome treatment.
Ramanathan R
Neonatology; 2009; 95(1):1-5. PubMed ID: 18832858
[TBL] [Abstract][Full Text] [Related]
22. [The pulmonary surfactant system: physiology, pathologies associated with its alteration and exogenous administration as therapeutic and diagnostic agent].
Calmanovici G; Boccio J; Lysionek A; Salgueiro M; Caro R; Hager A; de Paoli T; Zubillaga M
Acta Physiol Pharmacol Ther Latinoam; 1998; 48(4):175-90. PubMed ID: 9914807
[TBL] [Abstract][Full Text] [Related]
23. Surfactant replacement therapy for respiratory distress syndrome. American Academy of Pediatrics. Committee on Fetus and Newborn.
Pediatrics; 1999 Mar; 103(3):684-5. PubMed ID: 10049980
[TBL] [Abstract][Full Text] [Related]
24. [Surfactant treatment of acute pulmonary failure. Other indications than neonatal distress syndrome].
Silberg IE; Grønn M
Tidsskr Nor Laegeforen; 1997 Apr; 117(10):1456-8. PubMed ID: 9198922
[TBL] [Abstract][Full Text] [Related]
25. Surfactant replacement therapy for preterm and term neonates with respiratory distress.
Polin RA; Carlo WA; ;
Pediatrics; 2014 Jan; 133(1):156-63. PubMed ID: 24379227
[TBL] [Abstract][Full Text] [Related]
26. [Newer pathophysiologic considerations and treatment of neonatal respiratory distress syndrome (RDS)].
Fujiwara T
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Aug; 40(8):1033-43. PubMed ID: 3075225
[TBL] [Abstract][Full Text] [Related]
27. Surfactant replacement therapy.
Yu V
Indian Pediatr; 1998 Nov; 35(11):1081-96. PubMed ID: 10216542
[No Abstract] [Full Text] [Related]
28. Controversies: synthetic or natural surfactant treatment for respiratory distress syndrome? The case for synthetic surfactant.
Whitelaw A
J Perinat Med; 1996; 24(5):427-35. PubMed ID: 8950722
[TBL] [Abstract][Full Text] [Related]
29. Aerosolized surfactants.
Mazela J; Merritt TA; Finer NN
Curr Opin Pediatr; 2007 Apr; 19(2):155-62. PubMed ID: 17496758
[TBL] [Abstract][Full Text] [Related]
30. Respiratory distress syndrome in the newborn: innovative therapies.
Wiswell TE; Mendiola J
Am Fam Physician; 1993 Feb; 47(2):407-14. PubMed ID: 8430594
[TBL] [Abstract][Full Text] [Related]
31. Continuous positive airway pressure and surfactant.
Bohlin K; Jonsson B; Gustafsson AS; Blennow M
Neonatology; 2008; 93(4):309-15. PubMed ID: 18525215
[TBL] [Abstract][Full Text] [Related]
32. Animal-derived surfactants versus past and current synthetic surfactants: current status.
Moya F; Maturana A
Clin Perinatol; 2007 Mar; 34(1):145-77, viii. PubMed ID: 17394936
[TBL] [Abstract][Full Text] [Related]
33. Controversies regarding surfactant replacement therapy.
Shapiro DL; Notter RH
Clin Perinatol; 1988 Dec; 15(4):891-902. PubMed ID: 3061705
[TBL] [Abstract][Full Text] [Related]
34. Biochemical and pharmacological differences between preparations of exogenous natural surfactant used to treat Respiratory Distress Syndrome: role of the different components in an efficient pulmonary surfactant.
Blanco O; Pérez-Gil J
Eur J Pharmacol; 2007 Jul; 568(1-3):1-15. PubMed ID: 17543939
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the effects of surfactant replacement therapy in neonatal respiratory distress syndrome.
Ghaemi S; Mohamadymasodi M; Kelishadi R
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):188-90. PubMed ID: 19292953
[TBL] [Abstract][Full Text] [Related]
36. Surfactant replacement therapy: impact on hospital charges for premature infants with respiratory distress syndrome.
Maniscalco WM; Kendig JW; Shapiro DL
Pediatrics; 1989 Jan; 83(1):1-6. PubMed ID: 2909956
[TBL] [Abstract][Full Text] [Related]
37. [Drug treatments of respiratory distress syndrome in premature infants].
Saliba E; Laugier J
Pediatrie; 1993; 48(12):864-71. PubMed ID: 8047397
[TBL] [Abstract][Full Text] [Related]
38. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial.
Rojas MA; Lozano JM; Rojas MX; Laughon M; Bose CL; Rondon MA; Charry L; Bastidas JA; Perez LA; Rojas C; Ovalle O; Celis LA; Garcia-Harker J; Jaramillo ML;
Pediatrics; 2009 Jan; 123(1):137-42. PubMed ID: 19117872
[TBL] [Abstract][Full Text] [Related]
39. Exogenous surfactant therapy in newborns.
Rodriguez RJ; Martin RJ
Respir Care Clin N Am; 1999 Dec; 5(4):595-616. PubMed ID: 10565883
[TBL] [Abstract][Full Text] [Related]
40. [Preterm and term infants with acute respiratory distress syndrome (ARDS): what is the role of surfactant substitution?].
Wirbelauer J; Thomas W; Speer CP
Z Geburtshilfe Neonatol; 2009 Apr; 213(2):33-41. PubMed ID: 19319791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
